Production (Stage)
U
Jolt Health Inc. JTHTF
OTC PK
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
$606.17K
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
-$0.1478
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$625.40K
Net Income (TTM)
-$846.00K
Balance Sheet
Total Assets (Q)
$84.70K
Total Debt (Q)
$20.50K
Total Liabilities (Q)
$649.00K
Book Value Per Share (Q)
-$0.0887
Cash Flow
Cash from Operations (TTM)
-$367.00K
Cash from Investing (TTM)
-$11.30K
Cash from Financing (TTM)
$380.50K
Net Change in Cash (TTM)
$2.20K
Filings
Filing Date
Wednesday, April 30, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Aug 11 and 15 (est)
Price History
Loading...
Beta
--
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
-- - --
52-week High
-- - --
Valuation
Market Cap
$606.17K - Nano Cap
Enterprise Value
$675.73K
Price/Sales (TTM)
--
Price/Book (Q)
--
Dividends and Shares
Shares Outstanding
6.37M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
jolt-health.com
Phone Number
604 343 2977
Address
1780 -355 Burrard Street
Vancouver, BC V6C 2G8
Country
Canada
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Jolt Health Inc. operates as a licensee of technologies relating to substances and pharmaceutical grade therapeutics in Canada. The company focuses on sexual health, with or without the benefit... more